APP Series: Unraveling Hematological toxicities post CAR-T Cell therapy- Live
June 15, 2026
LEARNING OUTCOME
After participating in this APP Series, the learner will be able to describe the management of cancer patients with hematological toxicities due to CAR-T Cell Therapy utilizing evidence-based interventions.
REQUIREMENTS FOR SUCCESSFUL COMPLETION
- Sign In
- Attend the activity in full
- Complete session evaluation
TARGET AUDIENCE
Nurses and other healthcare professionals
If you have questions or comments please contact us at: [email protected].
TX
United States
PRESENTERS
Shini Theresia MSN,AGACNP-BC
CONFLICTS OF INTEREST
There are no conflict of interest for anyone with the ability to control content of this activity.
Available Credit
- 1.00 Contact Hour(s)UT Southwestern Medical Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Facebook
X
LinkedIn
Forward